Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Novartis to buy Regulus for $0.8 billion upfront with potential for $1.7B total based on ADPKD drug milestone; deal set to ...

Researchers at Karolinska Institutet and Uppsala University have developed a powerful new technique to better understand how ...

Over the last 7 days, the United States market has risen by 7.1%, with a 12-month increase of 7.7% and earnings forecasted to grow by 14% annually. In light of these conditions, investors may find ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 25.87%, which has investors questioning if this is right time to ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

New research suggests that octopuses and humans may share an ancient evolutionary connection that helps explain the ...

The test, developed by a team at the University of Southampton, uses AI to analyse blood samples for tiny fragments of ...

Early detection of colon cancer can prevent a majority of deaths, possibly as much as nine in 10 of them. Yet only about 69% ...

A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to ...

If you're looking to learn all about ESPN+ free trials and deals, you've come to the right place. Read on to find out how to get ESPN+ for less, what the latest plans cost, if ESPN+ has a free ...